comparemela.com

Almirall, S.A.: Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases

Almirall, S.A.: Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Spanish ,John Woolford ,Stefan Klotter ,Sumit Aggarwal ,Karl Ziegelbauer ,Laureen Cassidy ,Eloxx Pharmaceuticals Inc ,Eloxx Pharmaceuticals ,Corporate Communications ,Spanish Stock Exchange ,Dystrophic Epidermolysis Bullosa ,Junctional Epidermolysis Bullosa ,Chief Executive Officer ,Chief Scientific Officer ,Ribosome Modulating Agents ,Eukaryotic Ribosome Selective Glycosides ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Quarterly Report ,Divasson Del Fraile ,Lassen Sie ,

comparemela.com © 2020. All Rights Reserved.